Heart failure & cardiomyopathies

Cardiac magnetic resonance–derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy

EuropacePublished Retrospective cohort study

Authors' conclusion

Lower scar burden was associated with higher response rate of LBBAP-CRT.

Study context

Population
Patients with cardiac resynchronization therapy (CRT) indications who underwent cardiac magnetic resonance (CMR) and successful LBBAP-CRT
Participants
54 patients
Exposure
CMR-derived scar burden as predictor of response to LBBAP-CRT
Outcome
Echocardiographic response (≥15% reduction of LV end-systolic volume)
Methodological detailsconsecutive patients
  • Consecutive patients

Main finding

As reported in the abstract

Prediction of echocardiographic response
GroupAUC+LR-LR
Global scar %0.8579.8590.323
Septal scar %0.8645.5940.233
Lateral scar %0.8223.0590.175
Strauss LBBB0.6962.1010.389

AUC

Global scar %0.857
Septal scar %0.864
Lateral scar %0.822
Strauss LBBB0.696

+LR

Global scar %9.859
Septal scar %5.594
Lateral scar %3.059
Strauss LBBB2.101

-LR

Global scar %0.323
Septal scar %0.233
Lateral scar %0.175
Strauss LBBB0.389
Response rate with LBBAP-CRT
74.1%
Non-responders had higher global, septal and lateral scar burden
all P < 0.001

Observational data: associations, not effects.

Further findings

Composite of all-cause death or HF hospitalization · median follow-up 20.3 (11.5-38.7) months

HRP value
Higher global scar burden4.996P's < 0.05
Higher lateral scar burden7.019P's < 0.05
Higher septal scar burden4.741P's < 0.05

Original publication

Cardiac magnetic resonance–derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy. Europace. Published 31 October 2023. doi:10.1093/europace/euad326

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.